Drugs / FMT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03477916 | Apr 2018 → Jun 2020 | abdominal obesity-metabolic syndrome, obesity disorder | University of Alberta | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03477916 ↗ |
| Route | Oral | “taken by mouth on day 1 of the trial” NCT03477916 ↗ |